Loading…

Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy

Myocardial injury because of oxidative stress manifesting through reductions in left ventricular ejection fraction (LVEF) may occur after the administration of anthracycline-based chemotherapy (A-bC). We hypothesized that bilirubin, an effective endogenous antioxidant, may attenuate the reduction in...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2015-12, Vol.116 (11), p.1752-1755
Main Authors: Vera, Trinity, MD, D'Agostino, Ralph B., PhD, Jordan, Jennifer H., PhD, Whitlock, Matthew C., MD, Meléndez, Giselle C., MD, Lamar, Zanetta S., MD, Porosnicu, Mercedes, MD, Bonkovsky, Herbert L., MD, Poole, Leslie B., PhD, Hundley, W. Gregory, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Myocardial injury because of oxidative stress manifesting through reductions in left ventricular ejection fraction (LVEF) may occur after the administration of anthracycline-based chemotherapy (A-bC). We hypothesized that bilirubin, an effective endogenous antioxidant, may attenuate the reduction in LVEF that sometimes occurs after receipt of A-bC. We identified 751 consecutively treated patients with cancer who underwent a pre-A-bC LVEF measurement, exhibited a serum total bilirubin level
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2015.08.042